ReviewMaterials today. Bio2026
Targeting the neuro-immune-skin axis: Advanced functional biomaterials for intelligent wound management and regeneration.
Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic skin wounds and inflammatory skin diseases remain major clinical challenges because conventional dressings cannot dynamically respond to wound microenvironment changes. The emerging neuro-immune-skin axis concept highlights bidirectional communication between peripheral neurons and cutaneous immune cells mediated by neuropeptides, neurotransmitters, and cytokines, offering a new framework for advanced wound management. Unlike previous reviews that focus separately on neuroimmunology or wound biomaterials, this review integrates the two through the neuro-immune-skin axis. We systematically summarize the key molecular and cellular events of this triadic interplay, emphasizing how neural signals (e.g., substance P, CGRP) regulate immune cells and how immune mediators reciprocally affect neural and skin cells, while dissecting feedback loops. We then summarize recent biomaterial advances targeting this axis, including closed-loop regulatory approaches like neuro-immune crosstalk modulation, oxidative stress management, and pathology-triggered drug release, along with their applications in disease models. These materials are shifting from passive coverage to active intervention, steering wound healing toward neuroimmune-coordinated regeneration. Future integration of AI-assisted design, organoid-on-chip platforms, and smart closed-loop dressings may help overcome translational hurdles in biosafety, scalable manufacturing, and standardized evaluation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.